Aclaris Therapeutics, Inc. (LON: 0H8T)
London
· Delayed Price · Currency is GBP · Price in USD
2.510
+0.011 (0.44%)
Jan 22, 2025, 6:28 PM BST
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of 225.86 million as of January 23, 2025. Its market cap has increased by 283.15% in one year.
Market Cap
225.86M
Enterprise Value
86.86M
Revenue
20.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.51
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from 140.05M to 225.86M, an increase of 61.27%. That is a compound annual growth rate of 5.27%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 171.18B |
GSK plc | 55.31B |
Haleon | 33.62B |
Smith & Nephew | 8.96B |
ConvaTec Group | 4.93B |
Hikma Pharmaceuticals | 4.72B |
HUTCHMED (China) | 1.99B |
Oxford Nanopore Technologies | 1.44B |